Embla Medical hf. - Laporan Laba Rugi (TTM)

Embla Medical hf.
US ˙ OTCPK

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Embla Medical hf. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 639 630 637 692 701 719 728 719 715 719 730 750 766 786 804 820 840 855 858 874
Change (%) -1.55 1.15 8.71 1.23 2.56 1.28 -1.24 -0.50 0.48 1.55 2.80 2.16 2.51 2.37 1.91 2.51 1.74 0.34 1.83
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 245 238 239 252 257 263 270 271 271 279 283 288 293 300 310 313 319 320 316 326
Change (%) -2.59 0.21 5.50 1.83 2.64 2.74 0.12 0.03 2.95 1.33 1.97 1.84 2.26 3.42 0.90 1.92 0.32 -1.37 3.08
% of Revenue 38.25 37.85 37.50 36.39 36.61 36.63 37.16 37.68 37.87 38.81 38.72 38.41 38.29 38.20 38.59 38.20 37.98 37.45 36.81 37.27
Gross Operating Profit 395 391 398 440 444 455 457 448 444 440 447 462 473 486 494 507 521 535 542 548
Change (%) -0.91 1.73 10.63 0.88 2.52 0.44 -2.05 -0.82 -1.04 1.69 3.32 2.36 2.67 1.73 2.55 2.88 2.60 1.37 1.10
% of Revenue 61.75 62.15 62.50 63.61 63.39 63.37 62.84 62.32 62.13 61.19 61.28 61.59 61.71 61.80 61.41 61.80 62.02 62.55 63.19 62.73
SG&A 303 307 308 318 323 328 331 331 339 339 345 354 353 360 368 371 375 380 380 384
Change (%) 1.22 0.29 3.38 1.41 1.64 0.76 0.10 2.39 -0.06 1.85 2.58 -0.22 1.99 2.16 0.82 1.16 1.35 -0.02 1.16
% of Revenue 47.43 48.76 48.35 45.98 46.06 45.64 45.41 46.03 47.36 47.11 47.25 47.15 46.05 45.82 45.72 45.23 44.63 44.46 44.30 44.01
R&D 30 31 31 31 32 32 34 33 34 34 34 36 37 38 38 39 40 41 42 43
Change (%) 2.92 -0.49 2.03 0.89 -0.12 6.34 -1.30 0.75 1.39 1.33 5.22 1.71 3.38 0.30 2.79 1.56 2.24 1.77 3.30
% of Revenue 4.71 4.93 4.85 4.55 4.53 4.42 4.64 4.63 4.69 4.73 4.72 4.84 4.81 4.85 4.76 4.80 4.75 4.78 4.84 4.91
OpEx 578 576 577 602 611 623 635 635 643 652 662 678 683 698 716 723 734 741 737 753
Change (%) -0.31 0.22 4.18 1.56 1.97 1.88 0.03 1.30 1.29 1.60 2.46 0.76 2.18 2.60 0.96 1.51 0.95 -0.51 2.10
% of Revenue 90.39 91.54 90.69 86.92 87.20 86.69 87.21 88.34 89.93 90.66 90.70 90.40 89.16 88.87 89.06 88.23 87.37 86.69 85.96 86.19
Operating Income 61 53 59 91 90 96 93 84 72 67 68 72 83 87 88 96 106 114 120 121
Change (%) -13.29 11.26 52.79 -0.96 6.63 -2.63 -9.95 -14.11 -6.77 1.12 6.09 15.38 5.24 0.57 9.67 10.02 7.18 5.87 0.16
% of Revenue 9.61 8.46 9.31 13.08 12.80 13.31 12.79 11.66 10.07 9.34 9.30 9.60 10.84 11.13 10.94 11.77 12.63 13.31 14.04 13.81
Interest Expense -9 -10 -10 -11 -11 -10 -10 -9 -10 -11 -13 -17 -18 -18 -20 -19 -21 -23 -22 -21
Change (%) 3.61 3.84 9.12 -0.99 -9.13 -2.32 -8.25 8.44 17.66 15.08 29.79 6.14 1.10 8.81 -1.76 10.75 9.35 -3.31 -6.12
% of Revenue -1.45 -1.53 -1.57 -1.57 -1.54 -1.36 -1.31 -1.22 -1.33 -1.56 -1.77 -2.23 -2.32 -2.29 -2.43 -2.34 -2.53 -2.72 -2.62 -2.42
Net Income 20 6 11 48 50 64 62 57 47 43 43 45 52 58 57 61 69 68 72 73
Change (%) -68.58 72.11 344.35 4.90 28.37 -3.70 -7.28 -17.44 -9.88 2.26 3.90 15.79 11.64 -2.50 7.32 13.04 -1.14 5.71 1.33
% of Revenue 3.09 0.99 1.68 6.87 7.11 8.90 8.47 7.95 6.60 5.92 5.96 6.02 6.82 7.43 7.08 7.45 8.22 7.99 8.41 8.37

Source: Capital IQ

Other Listings
DK:EMBLA DKK 31.90
GB:EMBLAC
DE:5IQ
GB:0FIW
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista